Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure: Real-world data from a French hospital

BACKGROUND: In the context of personalized medicine, screening patients to identify targetable molecular alterations is essential for therapeutic decisions such as inclusion in clinical trials, early access to therapies, or compassionate treatment. The objective of this study was to determine the re...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinet, Sandra, Durand, Stéphanie, Perani, Alexandre, Darnaud, Léa, Amadjikpe, Fifame, Yon, Mathieu, Darbas, Tiffany, Vergnenegre, Alain, Egenod, Thomas, Simonneau, Yannick, Le Brun-Ly, Valérie, Pestre, Julia, Venat, Laurence, Thuillier, Frédéric, Chaunavel, Alain, Duchesne, Mathilde, Fermeaux, Véronique, Guyot, Anne, Lacorre, Sylvain, Bessette, Barbara, Lalloué, Fabrice, Durand, Karine, Deluche, Elise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009270/
https://www.ncbi.nlm.nih.gov/pubmed/36923436
http://dx.doi.org/10.3389/fonc.2023.1104659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009270/
https://www.ncbi.nlm.nih.gov/pubmed/36923436
http://dx.doi.org/10.3389/fonc.2023.1104659

Ejemplares similares